http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-306847-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd37543c9323a8491972bc8d6ed0fe04
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-02
filingDate 1929-02-25^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1930-01-23^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-306847-A
titleOfInvention Method of producing vanadium compounds
abstract 306,847. Schumacher, J. Feb. 24, 1928, [Convention date]. Void [Published under Sect. 91 of the Acts]. Vanadium derivatives of f aromatic arsenic compounds containing hydroxyl or amino groups are prepared by interaction of the arsenic compounds with vanadium compounds, and the products then reduced if desired. The bodies possess therapeutic properties. According to the exam. ples, (1) 4 : 4<1>-dihydroxy-3 : 3<1>-diaminoarseno. benzene dihydrochloride or its sodium salt is treated with sodium orthovanadate or ammonium metavanadate; the product may be acetylated, treated with phosgene, or reduced with sodium hydrosulphite; (2) the reduction product of the preceding example is added to an aqueous solution of the 4 : 4<1>-dihydroxy-3 : 3<1>-diaminoarsenobenzene dihydrochloride; (3) sodium dihydroxydiaminoarsenobenzene monomethylenesulphoxylate is treated with sodium orthovanadate; the product may be reduced with sodium hydrosulphite; (4) sodium p-hydroxy-m-aminophenylarsinate or its acetyl derivative is caused to react with sodium orthovanadate or ammonium metavanadate; the product may be reduced. with sodium hydrosulphite.
priorityDate 1928-02-24^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455858454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23397470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159667606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450108871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431909932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450992218
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18003865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453096772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449649868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453935431

Showing number of triples: 1 to 30 of 30.